, a bio/informatics shared resource is still "open for business" - Visit the CDS website

  1. Experimental myocardial infarction triggers canonical Wnt signaling and endothelial-to-mesenchymal transition. Aisagbonhi O, Rai M, Ryzhov S, Atria N, Feoktistov I, Hatzopoulos AK (2011) Dis Model Mech 4(4): 469-83
    › Primary publication · 21324930 (PubMed) · PMC3124051 (PubMed Central)
  2. Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial. Traverse JH, Henry TD, Ellis SG, Pepine CJ, Willerson JT, Zhao DX, Forder JR, Byrne BJ, Hatzopoulos AK, Penn MS, Perin EC, Baran KW, Chambers J, Lambert C, Raveendran G, Simon DI, Vaughan DE, Simpson LM, Gee AP, Taylor DA, Cogle CR, Thomas JD, Silva GV, Jorgenson BC, Olson RE, Bowman S, Francescon J, Geither C, Handberg E, Smith DX, Baraniuk S, Piller LB, Loghin C, Aguilar D, Richman S, Zierold C, Bettencourt J, Sayre SL, Vojvodic RW, Skarlatos SI, Gordon DJ, Ebert RF, Kwak M, Moyé LA, Simari RD, Cardiovascular Cell Therapy ResearchNetwork (2011) JAMA 306(19): 2110-9
    › Primary publication · 22084195 (PubMed) · PMC3600981 (PubMed Central)
  3. Discovering small molecules that promote cardiomyocyte generation by modulating Wnt signaling. Ni TT, Rellinger EJ, Mukherjee A, Xie S, Stephens L, Thorne CA, Kim K, Hu J, Lee E, Marnett L, Hatzopoulos AK, Zhong TP (2011) Chem Biol 18(12): 1658-68
    › Primary publication · 22195568 (PubMed) · PMC3645312 (PubMed Central)
  4. Time is like a clock in my heart: implications for stem cell delivery after myocardial infarction. Schoenhard JA, Hatzopoulos AK (2010) Cardiology 117(2): 158-60
    › Primary publication · 21042016 (PubMed) · PMC2992645 (PubMed Central)
  5. Thymosin beta4: a key factor for protective effects of eEPCs in acute and chronic ischemia. Hinkel R, Bock-Marquette I, Hatzopoulos AK, Hazopoulos AK, Kupatt C (2010) Ann N Y Acad Sci : 105-11
    › Primary publication · 20536456 (PubMed) · PMC3601487 (PubMed Central)
  6. Stem cell therapy: pieces of the puzzle. Schoenhard JA, Hatzopoulos AK (2010) J Cardiovasc Transl Res 3(1): 49-60
    › Primary publication · 20119487 (PubMed) · PMC2810366 (PubMed Central)
  7. NF kappaB activation in embryonic endothelial progenitor cells enhances neovascularization via PSGL-1 mediated recruitment: novel role for LL37. Pfosser A, El-Aouni C, Pfisterer I, Dietz M, Globisch F, Stachel G, Trenkwalder T, Pinkenburg O, Horstkotte J, Hinkel R, Sperandio M, Hatzopoulos AK, Boekstegers P, Bals R, Kupatt C (2010) Stem Cells 28(2): 376-85
    › Primary publication · 20014279 (PubMed)
  8. LateTIME: a phase-II, randomized, double-blinded, placebo-controlled, pilot trial evaluating the safety and effect of administration of bone marrow mononuclear cells 2 to 3 weeks after acute myocardial infarction. Traverse JH, Henry TD, Vaughan DE, Ellis SG, Pepine CJ, Willerson JT, Zhao DX, Simpson LM, Penn MS, Byrne BJ, Perin EC, Gee AP, Hatzopoulos AK, McKenna DH, Forder JR, Taylor DA, Cogle CR, Baraniuk S, Olson RE, Jorgenson BC, Sayre SL, Vojvodic RW, Gordon DJ, Skarlatos SI, Moyè LA, Simari RD, Cardiovascular Cell Therapy Research Network (2010) Tex Heart Inst J 37(4): 412-20
    › Primary publication · 20844613 (PubMed) · PMC2929864 (PubMed Central)
  9. Intramyocardial injection of autologous bone marrow mononuclear cells for patients with chronic ischemic heart disease and left ventricular dysfunction (First Mononuclear Cells injected in the US [FOCUS]): Rationale and design. Willerson JT, Perin EC, Ellis SG, Pepine CJ, Henry TD, Zhao DX, Lai D, Penn MS, Byrne BJ, Silva G, Gee A, Traverse JH, Hatzopoulos AK, Forder JR, Martin D, Kronenberg M, Taylor DA, Cogle CR, Baraniuk S, Westbrook L, Sayre SL, Vojvodic RW, Gordon DJ, Skarlatos SI, Moyé LA, Simari RD, Cardiovascular Cell Therapy Research Network (CCTRN) (2010) Am Heart J 160(2): 215-23
    › Primary publication · 20691824 (PubMed) · PMC2921924 (PubMed Central)
  10. Endothelial progenitors encapsulated in bioartificial niches are insulated from systemic cytotoxicity and are angiogenesis competent. Ratliff BB, Ghaly T, Brudnicki P, Yasuda K, Rajdev M, Bank M, Mares J, Hatzopoulos AK, Goligorsky MS (2010) Am J Physiol Renal Physiol 299(1): F178-86
    › Primary publication · 20410213 (PubMed) · PMC2904163 (PubMed Central)